DOXIMITY INC-CLASS A
DOCSNYSETrading Snapshot
- Day Range
- $26.39 – $26.85
- 52-Week Range
- $17.15 – $76.51
- Volume
- $6.92B
- Avg Volume
- $8.07B
- Shares Outstanding
- 187.0M
- Next Earnings
- Dec 9, 2026
Fundamentals Snapshot
- Annual Revenue
- $645M
- Last Q Revenue
- $157M
- P/E Ratio
- 29.4
- P/S Ratio
- 7.5x
- EPS (TTM)
- $0.91
- Dividend Yield
- 0.00%
- Dilution (1yr)
- −4.0%
Why Investors Own DOCS
- ✓High-growth profile — revenue up -8.4% YoY with expanding US Equity exposure.
- ✓Healthy economics — 35% gross margin and 24% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
DOXIMITY INC-CLASS A
DOCS
StockOtter · stockotter.spaceAbout DOXIMITY INC-CLASS A
Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations. Established in 2010, the entity initially operated as 3MD Communications, Inc. before rebranding to Doximity, Inc. in June of that year. The company's corporate headquarters are situated in San Francisco, California.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines – DOCS
NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS). Such investors are advised to contact Dan
Shareholders who lost money in shares of acquired Doximity, Inc. (NYSE: DOCS) should contact Wolf Haldenstein Immediately
NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”), a nationally recognized securities litigation law firm, announces that a class action lawsuit has been filed on
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCS
New York, New York--(Newsfile Corp. - September 29, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between August 8, 2024 and May 13, 202
DOCS Shareholder Alert: Doximity, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt
Doximity co-founder and former Chief Strategy Officer Nate Gross is named as a defendant in a securities class action alleging the Company assured investors it could "gain share" while older advertising formats were alle
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law
LOS ANGELES, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. (“Doximity” or “the
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Doximity, Inc. (DOCS)
NEW YORK, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf